Terremoto Biosciences Names Charles Baum As CEO
25 Jul 2024 //
BUSINESSWIRE
Terremoto Biosciences Closes $175 Million Series B Financing
02 Nov 2023 //
BUSINESSWIRE
OrbiMed and Third Rock’s Terremoto Bio raises $175M for small molecule R&D
02 Nov 2023 //
ENDPTS